Arvinas Inc

Healthcare · Biotechnology

7.60$ +1.7% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Arvinas Inc (ARVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 675 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARVN
Line item	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	38	–	–	–	67	116	106	99	199	187	172	209	302	282	263	272	717	682	644	1,605	1,582	1,488	1,407	1,335	1,269	1,176	1,084	1,058	1,305	1,213	1,280	1,167	1,091	1,001	909	844	718	648	675
Current Assets	37	36	–	–	66	114	104	96	196	180	163	200	291	270	250	258	703	665	628	1,576	1,553	1,457	1,376	1,305	1,240	1,148	1,057	1,033	1,280	1,190	1,257	1,150	1,067	980	890	826	701	631	652
Cash	5.1	-36	–	–	31	61	3.4	6.2	3.2	29	11	12	9.2	36	22	89	588	346	49	256	108	62	93	133	81	130	91	114	312	88	155	85	101	81	115	102	143	87	94
Cash & Short-Term Investments	–	36	–	–	39	113	100	90	188	175	159	191	281	263	243	249	689	651	601	1,544	1,503	1,428	1,343	1,271	1,205	1,124	1,039	999	1,261	1,169	1,229	1,122	1,039	954	861	788	685	615	568
Receivables	1.4	–	–	–	26	1.4	2.0	2.2	5.0	2.5	1.4	5.2	6.3	3.9	3.6	6.0	8.4	5.2	7.4	8.6	26	6.7	8.1	6.8	8.0	4.7	4.8	21	7.2	7.1	10	15	14	8.4	11	27	6.4	6.4	54
Inventory	–	–	–	–	–	–	–	–	0.0	–	–	–	–	–	–	0.0	–	–	4.5	4.5	-0.7	4.5	4.5	5.5	5.5	5.5	5.5	5.5	–	–	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	0.6	–	–	–	1.3	1.8	2.3	3.3	3.6	6.8	8.8	9.4	11	12	13	12	12	12	16	12	17	13	19	19	13	13	13	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	14	–	–	–	67	65	62	63	63	59	56	75	75	71	65	67	75	66	61	787	800	765	736	713	704	665	620	601	645	603	680	581	530	341	300	280	284	261	113
Current Liabilities	10	–	–	–	18	17	17	20	23	21	21	29	33	33	34	40	49	40	42	183	262	238	238	245	295	283	307	317	257	241	347	276	230	214	158	145	143	116	83
Short-Term Debt	0.1	0.5	–	–	0.2	0.2	0.2	0.2	0.2	0.6	0.7	0.6	0.7	0.9	0.9	0.9	1.0	1.2	1.2	1.1	1.1	1.7	1.7	1.8	1.8	2.0	2.0	2.1	1.9	1.5	1.2	0.8	1.8	1.9	1.8	1.9	1.7	1.8	2.1
Accounts Payable	1.6	–	–	–	0.6	2.0	1.7	1.3	2.8	1.6	1.4	2.3	4.6	3.0	2.4	5.1	7.1	9.0	5.0	4.7	31	8.6	12	7.9	5.7	12	6.7	34	18	18	23	18	13	26	17	18	24	31	7.5
Long-Term Debt	0.3	–	–	–	0.2	0.1	0.1	2.0	2.0	2.0	2.0	2.0	2.0	2.0	2.0	2.0	2.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.9	0.9	0.8	0.8	0.7	0.7	0.6	0.6	0.5	0.5	0.4	0.4	0.3	0.3
Shareholders' Equity	24	24	–	–	0.2	51	44	36	137	128	117	134	227	212	198	205	642	615	583	818	782	723	671	622	565	511	464	457	660	610	600	586	562	660	609	564	434	387	562
Retained Earnings	-34	–	–	–	-62	-138	-161	-286	-302	-317	-334	-352	-373	-394	-420	-450	-492	-533	-583	-630	-683	-746	-816	-883	-965	-1,047	-1,114	-1,178	-1,333	-1,402	-1,437	-1,487	-1,532	-1,449	-1,510	-1,545	-1,612	-1,670	-1,501
Shares Outstanding	–	1.9	1.9	21	21	21	31	32	31	31	31	33	37	39	39	39	42	49	49	50	53	53	53	53	53	53	53	54	61	72	72	72	72	73	73	73	65	64	66

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings